These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 17650100)
21. Effect of polyurethane chemistry and protein coating on monocyte differentiation towards a wound healing phenotype macrophage. McBane JE; Matheson LA; Sharifpoor S; Santerre JP; Labow RS Biomaterials; 2009 Oct; 30(29):5497-504. PubMed ID: 19635633 [TBL] [Abstract][Full Text] [Related]
22. What is the future of diabetic wound care? Sweitzer SM; Fann SA; Borg TK; Baynes JW; Yost MJ Diabetes Educ; 2006; 32(2):197-210. PubMed ID: 16554422 [TBL] [Abstract][Full Text] [Related]
23. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent. Trent JF; Kirsner RS Int J Clin Pract; 1998 Sep; 52(6):408-13. PubMed ID: 9894378 [TBL] [Abstract][Full Text] [Related]
24. An evaluation of healing metrics associated with commonly used advanced wound care products for the treatment of chronic diabetic foot ulcers. Fetterolf DE; Istwan NB; Stanziano GJ Manag Care; 2014 Jul; 23(7):31-8. PubMed ID: 25199368 [No Abstract] [Full Text] [Related]
25. A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds. Winters CL; Brigido SA; Liden BA; Simmons M; Hartman JF; Wright ML Adv Skin Wound Care; 2008 Aug; 21(8):375-81. PubMed ID: 18679086 [TBL] [Abstract][Full Text] [Related]
26. Treating recalcitrant diabetic wounds with hyaluronic acid: a review of patients. Ballard K; Cantor AJ Ostomy Wound Manage; 2003 Apr; 49(4):37-8, 40, 42, passim. PubMed ID: 12732739 [TBL] [Abstract][Full Text] [Related]
28. db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Michaels J; Churgin SS; Blechman KM; Greives MR; Aarabi S; Galiano RD; Gurtner GC Wound Repair Regen; 2007; 15(5):665-70. PubMed ID: 17971012 [TBL] [Abstract][Full Text] [Related]
29. Apligraf in the treatment of neuropathic diabetic foot ulcers. Edmonds M; Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997 [TBL] [Abstract][Full Text] [Related]
30. The role of skin substitutes in the treatment of burn injuries. Shakespeare PG Clin Dermatol; 2005; 23(4):413-8. PubMed ID: 16023937 [TBL] [Abstract][Full Text] [Related]
31. Tissue-engineered skin substitutes: from in vitro constructs to in vivo applications. Auger FA; Berthod F; Moulin V; Pouliot R; Germain L Biotechnol Appl Biochem; 2004 Jun; 39(Pt 3):263-75. PubMed ID: 15154837 [TBL] [Abstract][Full Text] [Related]
32. Biological skin substitutes for wound cover and closure. Hrabchak C; Flynn L; Woodhouse KA Expert Rev Med Devices; 2006 May; 3(3):373-85. PubMed ID: 16681458 [TBL] [Abstract][Full Text] [Related]
33. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Spiekstra SW; Breetveld M; Rustemeyer T; Scheper RJ; Gibbs S Wound Repair Regen; 2007; 15(5):708-17. PubMed ID: 17971017 [TBL] [Abstract][Full Text] [Related]
34. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers. Karr J Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250 [TBL] [Abstract][Full Text] [Related]
37. Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects. Krishnan ST; Quattrini C; Jeziorska M; Malik RA; Rayman G Diabetes Care; 2007 Dec; 30(12):3058-62. PubMed ID: 17898089 [TBL] [Abstract][Full Text] [Related]
38. Wound closure and metabolic parameter variability in a db/db mouse model for diabetic ulcers. Trousdale RK; Jacobs S; Simhaee DA; Wu JK; Lustbader JW J Surg Res; 2009 Jan; 151(1):100-7. PubMed ID: 18619614 [TBL] [Abstract][Full Text] [Related]